Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT. (PubMed, Transpl Infect Dis) - Mar 2, 2026 - "An analysis of real-world use of letermovir in CMV prophylaxis after allo-HCT showed a low incidence of csCMVi compared to previously published information."
Journal • Real-world evidence • Retrospective data • Bone Marrow Transplantation • Cytomegalovirus Infection • Graft versus Host Disease • Hematological Malignancies • Immunology • Infectious Disease • Leukemia • Oncology • Transplantation
|
|
Alida Dominietto; Aliénor Xhaard; Andrew P Beyer; Angelo Michele Carella; Annie Ferreri; David Beauvais; Deepa Patel; Dina Averbuch; Domenico Russo; Emma Kempshall; Francesco Onida; Gloria Tridello; Ilaria Cutini; Irina Kolobova; Jan Styczynski; Leotta Salvatore; Lotus Wendel; Maria Catarina Mico; Nina Knelange; Patrizia Chiusolo; Per Ljungman; Rafael de la Camara; Sabrina Kraus; Uwe Platzbecker; Varun Mehra; Vincenzo Federico; Yuexin Tang
|